{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:20:38Z","timestamp":1790796038972,"version":"4.1.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1124\/jpet.123.001962","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T18:05:15Z","timestamp":1706033115000},"page":"203-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions"],"prefix":"10.1016","volume":"390","author":[{"given":"Dalila Andrade","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7790-2550","authenticated-orcid":false,"given":"Fabiano Beraldi","family":"Calmasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-5570","authenticated-orcid":false,"given":"F\u00e1bio Henrique","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001962_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.113.211029","article-title":"Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770","volume":"349","author":"Alexandre","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001962_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/pr.111.004515","article-title":"Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction","volume":"63","author":"Andersson","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.123.001962_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jsm.12816","article-title":"Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors","volume":"12","author":"Anele","year":"2015","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib4","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1182\/blood-2014-09-551887","article-title":"How I treat priapism","volume":"125","author":"Anele","year":"2015","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001962_bib5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s11255-014-0737-7","article-title":"Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature","volume":"46","author":"Anele","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1124\/jpet.123.001962_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/03630269.2018.1452760","article-title":"Prevalence and Characteristics of Priapism in Sickle Cell Disease","volume":"42","author":"Arduini","year":"2018","journal-title":"Hemoglobin"},{"key":"10.1124\/jpet.123.001962_bib7","doi-asserted-by":"crossref","first-page":"15215","DOI":"10.1073\/pnas.221292098","article-title":"Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease","volume":"98","author":"Aslan","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001962_bib8","doi-asserted-by":"crossref","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.1124\/jpet.123.001962_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1537-2995.2006.00679.x","article-title":"Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia","volume":"46","author":"Ballas","year":"2006","journal-title":"Transfusion"},{"key":"10.1124\/jpet.123.001962_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196455","article-title":"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction","volume":"13","author":"Belcher","year":"2018","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001962_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001962_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0090-4295(02)02121-0","article-title":"BAY 41-2272: a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo","volume":"61","author":"Bischoff","year":"2003","journal-title":"Urology"},{"key":"10.1124\/jpet.123.001962_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JU.0000000000002767","article-title":"The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients, and Non-Ischemic Priapism: An AUA\/SMSNA Guideline","volume":"208","author":"Bivalacqua","year":"2022","journal-title":"J Urol"},{"key":"10.1124\/jpet.123.001962_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068028","article-title":"Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress","volume":"8","author":"Bivalacqua","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001962_bib15","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/j.1743-6109.2009.01359.x","article-title":"Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism","volume":"6","author":"Bivalacqua","year":"2009","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2020.01323","article-title":"Pro-inflammatory Actions of Heme and Other Hemoglobin-Derived DAMPs","volume":"11","author":"Bozza","year":"2020","journal-title":"Front Immunol"},{"key":"10.1124\/jpet.123.001962_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.molmed.2020.02.004","article-title":"Haptoglobin Therapeutics and Compartmentalization of Cell-Free Hemoglobin Toxicity","volume":"26","author":"Buehler","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.123.001962_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.ju.0000046303.22757.f2","article-title":"Pathophysiology of Priapism: Dysregulatory Erection Physiology Thesis","volume":"170","author":"Burnett","year":"2003","journal-title":"J Urol"},{"key":"10.1124\/jpet.123.001962_bib19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"127","author":"Burnett","year":"2014","journal-title":"Am J Med"},{"key":"10.1124\/jpet.123.001962_bib20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1743-6109.2006.00333.x","article-title":"Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism","volume":"3","author":"Burnett","year":"2006","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib21","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.urology.2005.11.045","article-title":"Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism","volume":"67","author":"Burnett","year":"2006","journal-title":"Urology"},{"key":"10.1124\/jpet.123.001962_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/j.1939-4640.2002.tb02601.x","article-title":"Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase","volume":"23","author":"Burnett","year":"2002","journal-title":"J Androl"},{"key":"10.1124\/jpet.123.001962_bib23","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0407183102","article-title":"Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism","volume":"102","author":"Champion","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001962_bib24","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.001962_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154866","article-title":"Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength","volume":"11","author":"Cita","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001962_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1464-410X.2010.09776.x","article-title":"Long-term oral treatment with BAY 41-2272 ameliorates impaired corpus cavernosum relaxations in a nitric oxide-deficient rat model","volume":"108","author":"Claudino","year":"2011","journal-title":"BJU Int"},{"key":"10.1124\/jpet.123.001962_bib27","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1046\/j.1432-1327.2000.01297.x","article-title":"Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities","volume":"267","author":"Corbin","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1124\/jpet.123.001962_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2012.05.009","article-title":"Vas deferens smooth muscle responses to the nitric oxide-independent soluble guanylate cyclase stimulator BAY 41-2272","volume":"688","author":"da Silva","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001962_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3945\/ajcn.112.036319","article-title":"Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial","volume":"97","author":"Daak","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1124\/jpet.123.001962_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/ijms20010187","article-title":"New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function\/Dysfunction in Cardiovascular Disease","volume":"20","author":"Daiber","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.123.001962_bib31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1742-1241.2010.02355.x","article-title":"A practical guide to male hypogonadism in the primary care setting","volume":"64","author":"Dandona","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1124\/jpet.123.001962_bib32","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1021\/jm300602n","article-title":"Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms. part II: furoxan derivatives","volume":"55","author":"Dos Santos","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001962_bib33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.119.264606","article-title":"Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo Studies","volume":"374","author":"Ferreira","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001962_bib34","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.1074\/jbc.M610737200","article-title":"Characterization of heme as activator of Toll-like receptor 4","volume":"282","author":"Figueiredo","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.123.001962_bib35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.123.001962_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.apha.2016.04.001","article-title":"Transcriptional and Posttranslational Regulation of eNOS in the Endothelium","volume":"77","author":"Fulton","year":"2016","journal-title":"Adv Pharmacol"},{"key":"10.1124\/jpet.123.001962_bib37","doi-asserted-by":"crossref","first-page":"561917","DOI":"10.3389\/fimmu.2020.561917","article-title":"The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease","volume":"11","author":"Gbotosho","year":"2021","journal-title":"Front Immunol"},{"key":"10.1124\/jpet.123.001962_bib38","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/S0140-6736(16)00647-4","article-title":"Cardiovascular complications and risk of death in sickle-cell disease","volume":"387","author":"Gladwin","year":"2016","journal-title":"Lancet"},{"key":"10.1124\/jpet.123.001962_bib39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1365-2141.2002.03274.x","article-title":"Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease","volume":"116","author":"Gladwin","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.123.001962_bib40","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0026-895X(24)23250-8","article-title":"Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea","volume":"55","author":"Glover","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.123.001962_bib41","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.001962_bib42","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2174\/138161210791164162","article-title":"Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction","volume":"16","author":"Gur","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.123.001962_bib43","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/andr.12370","article-title":"Reproductive endocrine issues in men with sickle cell anemia","volume":"5","author":"Huang","year":"2017","journal-title":"Andrology"},{"key":"10.1124\/jpet.123.001962_bib44","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1172\/JCI24650","article-title":"Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control","volume":"115","author":"Huang","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.123.001962_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.21037\/tau.2017.01.18","article-title":"Advances in the understanding of priapism","volume":"6","author":"Hudnall","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1124\/jpet.123.001962_bib46","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1182\/blood-2005-03-1185","article-title":"Identification of the receptor scavenging hemopexin-heme complexes","volume":"106","author":"Hvidberg","year":"2005","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001962_bib47","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200867R","article-title":"Intravascular hemolysis leads to exaggerated corpus cavernosum relaxation: Implication for priapism in sickle cell disease","volume":"36","author":"Iacopucci","year":"2022","journal-title":"FASEB J"},{"key":"10.1124\/jpet.123.001962_bib48","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/bloodadvances.2020002062","article-title":"Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease","volume":"4","author":"Idris","year":"2020","journal-title":"Blood Adv"},{"key":"10.1124\/jpet.123.001962_bib49","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.freeradbiomed.2006.08.017","article-title":"Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias","volume":"41","author":"Jeffers","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/jpet.123.001962_bib50","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001962_bib51","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1124\/jpet.123.001962_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle Cell Disease: A Review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.001962_bib53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/CH-189009","article-title":"Nitric oxide pathology and therapeutics in sickle cell disease","volume":"68","author":"Kim-Shapiro","year":"2018","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1124\/jpet.123.001962_bib54","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","article-title":"Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis","volume":"189","author":"Lagoda","year":"2013","journal-title":"J Urol"},{"key":"10.1124\/jpet.123.001962_bib55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1096\/fj.13-228817","article-title":"Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism","volume":"28","author":"Lagoda","year":"2014","journal-title":"FASEB J"},{"key":"10.1124\/jpet.123.001962_bib56","doi-asserted-by":"crossref","first-page":"H1670","DOI":"10.1152\/ajpheart.00062.2013","article-title":"The sGC activator BAY 60-2770 has potent erectile activity in the rat","volume":"304","author":"Lasker","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.123.001962_bib57","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.juro.2013.09.020","article-title":"The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice","volume":"191","author":"Leiria","year":"2014","journal-title":"J Urol"},{"key":"10.1124\/jpet.123.001962_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.ijir.3900802","article-title":"Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters","volume":"14","author":"Lin","year":"2002","journal-title":"Int J Impot Res"},{"key":"10.1124\/jpet.123.001962_bib59","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","article-title":"The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics","volume":"7","author":"Lundberg","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.123.001962_bib60","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ucl.2021.06.009","article-title":"Physiology of Erection and Pathophysiology of Erectile Dysfunction","volume":"48","author":"MacDonald","year":"2021","journal-title":"Urol Clin North Am"},{"key":"10.1124\/jpet.123.001962_bib61","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI33467","article-title":"Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling","volume":"118","author":"Mi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.123.001962_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrurol.2017.181","article-title":"Stimulators and activators of soluble guanylate cyclase for urogenital disorders","volume":"15","author":"M\u00f3nica","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1124\/jpet.123.001962_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.001962_bib64","first-page":"179","article-title":"Testosterone Replacement Therapy in Adolescents With Sickle Cell Disease Reverses Hypogonadism Without Promoting Priapism: A Case Report","volume":"3","author":"Morrison","year":"2015","journal-title":"Urol Case Rep"},{"key":"10.1124\/jpet.123.001962_bib65","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.2047-2927.2013.00084.x","article-title":"Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report","volume":"1","author":"Morrison","year":"2013","journal-title":"Andrology"},{"key":"10.1124\/jpet.123.001962_bib66","first-page":"10","article-title":"Sickle cell disease celebration","volume":"19","author":"Mullard","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.123.001962_bib67","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","article-title":"Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases","volume":"32","author":"Muller-Eberhard","year":"1968","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001962_bib68","doi-asserted-by":"crossref","first-page":"116922","DOI":"10.1016\/j.lfs.2019.116922","article-title":"Dysregulated NO\/PDE5 signaling in the sickle cell mouse lower urinary tract: Reversal by oral nitrate therapy","volume":"238","author":"Musicki","year":"2019","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001962_bib69","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jsm.12391","article-title":"Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis","volume":"11","author":"Musicki","year":"2014","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib600","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14728222.2020.1745188","article-title":"Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape","volume":"24","author":"Musicki","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"10.1124\/jpet.123.001962_bib70","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1743-6109.2010.02123.x","article-title":"Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse penis","volume":"8","author":"Musicki","year":"2011","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/andr.12442","article-title":"Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis","volume":"6","author":"Musicki","year":"2018","journal-title":"Andrology"},{"key":"10.1124\/jpet.123.001962_bib72","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/jcp.30075","article-title":"TSPO ligand FGIN-1-27 controls priapism in sickle cell mice via endogenous testosterone production","volume":"236","author":"Musicki","year":"2021","journal-title":"J Cell Physiol"},{"key":"10.1124\/jpet.123.001962_bib73","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1743-6109.2012.02798.x","article-title":"Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis","volume":"9","author":"Musicki","year":"2012","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128694","article-title":"Mechanism of testosterone deficiency in the transgenic sickle cell mouse","volume":"10","author":"Musicki","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001962_bib75","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1096\/fj.13-247833","article-title":"Excess adenosine A2B receptor signaling contributes to priapism through HIF-1\u03b1 mediated reduction of PDE5 gene expression","volume":"28","author":"Ning","year":"2014","journal-title":"FASEB J"},{"key":"10.1124\/jpet.123.001962_bib76","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1182\/blood-2005-04-1594","article-title":"Hemolysis-associated priapism in sickle cell disease","volume":"106","author":"Nolan","year":"2005","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001962_bib77","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.lfs.2017.10.014","article-title":"Toll-like receptor 4 (TLR4) impairs nitric oxide contributing to Angiotensin II-induced cavernosal dysfunction","volume":"191","author":"Nunes","year":"2017","journal-title":"Life Sci"},{"key":"10.1124\/jpet.123.001962_bib78","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jsxm.2018.07.005","article-title":"Blockade of Toll-Like Receptor 4 Attenuates Erectile Dysfunction in Diabetic Rats","volume":"15","author":"Nunes","year":"2018","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib79","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00277-011-1404-z","article-title":"N-acetylcysteine reduces oxidative stress in sickle cell patients","volume":"91","author":"Nur","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1124\/jpet.123.001962_bib80","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.123.001962_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292706","article-title":"Hydroxyurea does not reverse functional alterations of the nitric oxide-cGMP pathway associated with priapism phenotype in corpus cavernosum from sickle cell mouse","volume":"18","author":"Pereira","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1124\/jpet.123.001962_bib82","doi-asserted-by":"crossref","first-page":"961534","DOI":"10.3389\/fphys.2022.961534","article-title":"Haptoglobin treatment contributes to regulating nitric oxide signal and reduces oxidative stress in the penis: A preventive treatment for priapism in sickle cell disease","volume":"13","author":"Pereira","year":"2022","journal-title":"Front Physiol"},{"key":"10.1124\/jpet.123.001962_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269310","article-title":"Resveratrol-nitric oxide donor hybrid effect on priapism in sickle cell and nitric oxide-deficient mouse","volume":"17","author":"Pinheiro","year":"2022","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001962_bib84","doi-asserted-by":"crossref","first-page":"8416763","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative Stress: Harms and Benefits for Human Health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1124\/jpet.123.001962_bib85","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jsxm.2016.06.004","article-title":"Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction","volume":"13","author":"Podlasek","year":"2016","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib86","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1165\/rcmb.2017-0292OC","article-title":"Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease","volume":"58","author":"Potoka","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.123.001962_bib87","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1440-1681.2005.04262.x","article-title":"Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator","volume":"32","author":"Priviero","year":"2005","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/jpet.123.001962_bib88","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1021\/ar300234c","article-title":"Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects","volume":"46","author":"Radi","year":"2013","journal-title":"Acc Chem Res"},{"key":"10.1124\/jpet.123.001962_bib89","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/jpet.123.001962_bib90","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.20142","article-title":"Follow-up of sickle cell disease patients with priapism treated by hydroxyurea","volume":"77","author":"Saad","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1124\/jpet.123.001962_bib91","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.123.001962_bib92","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/164_2018_197","article-title":"Soluble Guanylate Cyclase Stimulators and Activators","volume":"264","author":"Sandner","year":"2021","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/jpet.123.001962_bib93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcmd.2018.07.002","article-title":"Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patients","volume":"72","author":"Santiago","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"10.1124\/jpet.123.001962_bib94","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1164\/rccm.201510-2058OC","article-title":"Haptoglobin Preserves Vascular Nitric Oxide Signaling during Hemolysis","volume":"193","author":"Schaer","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.123.001962_bib95","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"key":"10.1124\/jpet.123.001962_bib96","doi-asserted-by":"crossref","first-page":"101072","DOI":"10.1016\/j.redox.2018.101072","article-title":"The impact of xanthine oxidase (XO) on hemolytic diseases","volume":"21","author":"Schmidt","year":"2019","journal-title":"Redox Biol"},{"key":"10.1124\/jpet.123.001962_bib97","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.14280","article-title":"Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function","volume":"175","author":"Shi","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1124\/jpet.123.001962_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166291","article-title":"Sympathetic Hyperactivity, Increased Tyrosine Hydroxylase and Exaggerated Corpus Cavernosum Relaxations Associated with Oxidative Stress Plays a Major Role in the Penis Dysfunction in Townes Sickle Cell Mouse","volume":"11","author":"Silva","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.123.001962_bib99","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/jpet.116.235473","article-title":"Beneficial Effect of the Nitric Oxide Donor Compound 3-(1,3-Dioxoisoindolin-2-yl)Benzyl Nitrate on Dysregulated Phosphodiesterase 5, NADPH Oxidase and Nitrosative Stress in the Sickle Cell Mouse Penis: Implication for Priapism Treatment","volume":"359","author":"Silva","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001962_bib100","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1111\/jsm.12682","article-title":"Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice","volume":"11","author":"Silva","year":"2014","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib101","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/bj1820047","article-title":"Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein","volume":"182","author":"Smith","year":"1979","journal-title":"Biochem J"},{"key":"10.1124\/jpet.123.001962_bib102","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/jsm.12976","article-title":"Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation","volume":"12","author":"Sopko","year":"2015","journal-title":"J Sex Med"},{"key":"10.1124\/jpet.123.001962_bib103","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1021\/jm960379t","article-title":"Water soluble furoxan derivatives as NO prodrugs","volume":"40","author":"Sorba","year":"1997","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001962_bib104","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35065611","article-title":"NO-independent regulatory site on soluble guanylate cyclase","volume":"410","author":"Stasch","year":"2001","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001962_bib105","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.123.001962_bib106","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.001962_bib107","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJMsr1503311","article-title":"Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics","volume":"373","author":"Steinhorn","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.001962_bib108","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000337344","article-title":"Hypogonadism in patients with sickle cell disease: central or peripheral?","volume":"128","author":"Taddesse","year":"2012","journal-title":"Acta Haematol"},{"key":"10.1124\/jpet.123.001962_bib109","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1111\/bph.15492","article-title":"Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease","volume":"178","author":"Tchernychev","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001962_bib110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: towards a multi-agent approach","volume":"18","author":"Telen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.123.001962_bib111","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/ars.2018.7583","article-title":"Vascular Biology of Superoxide-Generating NADPH Oxidase 5-Implications in Hypertension and Cardiovascular Disease","volume":"30","author":"Touyz","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.123.001962_bib112","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.esxm.2019.10.003","article-title":"Testosterone Induces Relaxation of Human Corpus Cavernosum Tissue of Patients With Erectile Dysfunction","volume":"8","author":"Van den Broeck","year":"2020","journal-title":"Sex Med"},{"key":"10.1124\/jpet.123.001962_bib113","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/CIRCULATIONAHA.112.130179","article-title":"Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases","volume":"127","author":"Vinchi","year":"2013","journal-title":"Circulation"},{"key":"10.1124\/jpet.123.001962_bib114","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","article-title":"NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets","volume":"17","author":"Zhang","year":"2020","journal-title":"Nat Rev Cardiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524002039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:38:53Z","timestamp":1774960733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524002039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0022356524002039"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001962","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric Oxide Resistance in Priapism Associated with Sickle Cell Disease: Mechanisms, Therapeutic Challenges, and Future Directions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}